Literature DB >> 2173738

Adenovirus infection in patients with Kawasaki disease.

M Okano1, G M Thiele, Y Sakiyama, S Matsumoto, D T Purtilo.   

Abstract

Two outbreaks of Kawasaki disease at different times and areas (Kyoto in 1982 and Sapporo in 1985) of Japan were studied retrospectively for the presence of antibodies to adenoviruses and herpesviruses. Only 2 of 12 (16.7%) consecutive acute phase sera of patients from the outbreak in 1982 and 1 of 10 (10.0%) sera from 1985 showed positive antibodies for the common adenovirus antigen by a complement fixation (CF) test, whereas 10 of 16 (62.5%) age- and sex-matched controls during the outbreak of Kawasaki disease in 1985 were seropositive by the CF test. In contrast, using a recently developed enzyme-linked immunosorbent assay (ELISA), 9 patients (75.0%) in 1982 and 9 patients (90.0%) in 1985 had antibodies to adenovirus type 2. In addition, 5 of 10 (50.0%) of the 1982 and 6 of 9 (66.7%) of the 1985 patients who were seronegative for CF antibodies were positive for IgM antibodies to adenovirus type 2. Fifteen (93.8%) controls were positive for antibodies to adenovirus type 2 by ELISA and only two sera showed negative CF antibodies with positive IgM antibodies to adenovirus type 2. Sequential sera from 4 patients in 1985 had either IgM or IgG antibodies by ELISA and eventually three became seropositive by the CF test in time. Additionally, no significant difference was noted with antibody status to herpes simplex virus type 1 and 2 (HSV-1 and HSV-2), varicella zoster virus (VZV), and cytomegalovirus (CMV) between patients and controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173738     DOI: 10.1002/jmv.1890320109

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Concomitant respiratory viral infections in children with Kawasaki disease.

Authors:  Alejandro Jordan-Villegas; Michael L Chang; Octavio Ramilo; Asunción Mejías
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

2.  Phantom cytomegalovirus infection in vasculitis patients: what it means and what to do.

Authors:  Konstantinos H Katsanos; Aggeliki Kostoula; Konstantinos P Katopodis; Kostas C Siamopoulos
Journal:  Rheumatol Int       Date:  2004-10-16       Impact factor: 2.631

3.  Epstein-Barr virus antibodies in Kawasaki disease.

Authors:  Soon-Ju Lee; Kyung-Yil Lee; Ji-Whan Han; Joon-Sung Lee; Kyung-Tai Whang
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

4.  Discrimination of Kawasaki disease with concomitant adenoviral detection differentiating from isolated adenoviral infection.

Authors:  Jong Han Kim; Hye Ree Kang; Su Yeong Kim; Ji-Eun Ban
Journal:  Korean J Pediatr       Date:  2018-02-28

Review 5.  Kawasaki Disease: The Role of Immune Complexes Revisited.

Authors:  Stephanie Menikou; Paul R Langford; Michael Levin
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

Review 6.  Kawasaki disease: what is the epidemiology telling us about the etiology?

Authors:  David Burgner; Anthony Harnden
Journal:  Int J Infect Dis       Date:  2005-07       Impact factor: 3.623

7.  Molecular and clinical characteristics of adenoviral infections in Taiwanese children in 2004-2005.

Authors:  Chia-Chi Cheng; Li-Min Huang; Chuan-Liang Kao; Ping-Ing Lee; Jong-Min Chen; Chun-Yi Lu; Chin-Yun Lee; Sui-Yuan Chang; Luan-Yin Chang
Journal:  Eur J Pediatr       Date:  2007-09-18       Impact factor: 3.860

8.  Decreasing fertility rate correlates with the chronological increase and geographical variation in incidence of Kawasaki disease in Japan.

Authors:  Yoshiro Nagao
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240

Review 9.  Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota.

Authors:  Kazunari Kaneko; Shohei Akagawa; Yuko Akagawa; Takahisa Kimata; Shoji Tsuji
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

Review 10.  Infection and vasculitis.

Authors:  Cristina C Belizna; Mohamed A Hamidou; Hervé Levesque; Loic Guillevin; Yehuda Shoenfeld
Journal:  Rheumatology (Oxford)       Date:  2009-03-03       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.